ZTH-31694-54313
3 vaccinations
9 coded responses
14 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 900 / CA
- Registered
- 2021-06-04
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-05-13
Dose 1 — Pfizer-BioNTech
-
2021-06-03
Dose 2 — Pfizer-BioNTech
-
2021-06-04
Registered in v-safe
-
2021-06-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-06-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-06-06
Survey response — days 1–6 daily, dose 2MedDRA: Chest discomfort, Hot flush — Feeling: GoodFree text: Chest discomfort, hot flashesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-07
-
2021-06-08
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Mild soreness at the injection site with exerciseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-09
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain, Pain — Feeling: Good · Site: PainFree text: Pain at the injection site when exercisingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-17
-
2021-06-24
Survey response — day 21, dose 2MedDRA: Asthenia, Dyspnoea, Exercise tolerance decreased — Feeling: GoodFree text: I run out of breath easily and have low energy, since the vaccine. I am not able to keep up with the exercise I was used to, pre vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-01
Survey response — day 28, dose 2MedDRA: Dyspnoea — Feeling: GoodFree text: Difficulty breathing when exercising since receiving the shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-08
Survey response — day 35, dose 2MedDRA: Dyspnoea exertional — Feeling: Good · Be unable to do your normal daily activitiesFree text: Still running out of breath easily and difficulty breathing with activity (walking and exercise).For the following response my normal activities such as walking and exercise did not cause me to run out of breath as they do now.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-17
Survey response — day 42, dose 2MedDRA: Arthralgia, Dyspnoea — Feeling: GoodFree text: Out of breath easier, joint pain.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-02
Survey response — 3 months, dose 2MedDRA: Arthralgia — Feeling: GoodFree text: Shoulder joint painMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-12-04
-
2021-12-23
Dose 3 — Pfizer-BioNTech
-
2022-06-03
Survey response — 12 months, dose 2MedDRA: Dyspnoea, Hypersensitivity, Pre-existing disease — Feeling: GoodFree text: Shortness of breath remains, more sensitive to outdoor allergies.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-13 | Pfizer-BioNTech | |
| 2 | 2021-06-03 | Pfizer-BioNTech | |
| 3 | 2021-12-23 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Chest discomfort, hot flashes
Systemic reaction (other): Mild soreness at the injection site with exercise
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Pain at the injection site when exercising
Release 9 — day 21, dose 2
Symptoms: I run out of breath easily and have low energy, since the vaccine. I am not able to keep up with the exercise I was used to, pre vaccine.
Release 9 — day 28, dose 2
Symptoms: Difficulty breathing when exercising since receiving the shot.
Release 9 — day 35, dose 2
Symptoms: Still running out of breath easily and difficulty breathing with activity (walking and exercise).For the following response my normal activities such as walking and exercise did not cause me to run out of breath as they do now.
Release 9 — day 42, dose 2
Symptoms: Out of breath easier, joint pain.
Release 9 — 3 months, dose 2
Symptoms: Shoulder joint pain
Release 11 — 12 months, dose 2
Symptoms: Shortness of breath remains, more sensitive to outdoor allergies.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | · | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Exercise tolerance decreased | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release